Europace

Article	Citations
How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?	397
Atrioventricular dromotropathy: an important substrate for complete resynchronization therapy—Authors’ reply	289
Administrative data confirm safety of same-day discharge following catheter ablation of atrial fibrillation: all good or is there a fly in the ointment?	285
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	276
Atrial cardiomyopathy delays the endothelialization process of left atrial appendage occluders	225
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	205
Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial	189
Device-lead abnormalities and function after transcatheter tricuspid valve replacement	151
Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement	149
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	131
Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance	127
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review	125
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	116
Impact of pulsed-field ablation on kidney function	116
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	103
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	101
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	92
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	92
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	91
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	90
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	89
Failed shocks in hypertrophic cardiomyopathy patients: prevalence, predictors and outcome	86
Left bundle branch area pacing: predictors of success	86
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	78
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	70

Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	69
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	64
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	62
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	60
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	60
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	59
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	59
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	59
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	59
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	58
Computed tomography as a predictive tool for ventricular tachycardia	57
Prevalence and clinical impact of major incidental findings detected on routine cardiovascular resonance imaging prior to catheter ablation of atrial fibrillation	57
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	56
Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application	56
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	55
Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	54
Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium	54
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	52
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	52
Pre-diabetes increases the risk of heart failure among patients with nonvalvular atrial fibrillation	50
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	49
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	48
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	48
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	47
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	46
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	46
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	45
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	45
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	45
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	45
High-density sequential mapping of repetitive atrial conduction patterns during atrial fibrillation	44
Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V	44
First experience of focal pulsed field ablation for premature ventricular contractions	44
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	43
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	43
The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter	43
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	42
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	41
Impaired heart rate variability triangular index predicts stroke and systemic embolism in patients with atrial fibrillation	41
Discussions on implantable cardioverter defibrillator deactivation in patients receiving radiation therapy	41
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	41
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	40
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	40
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	40
MicroPort CRM considerations on Vega pacing lead performance	40
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	39
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	38
LAT velocity vectors: a novel tool for ventricular functional substrate characterization	38
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	38
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	38

Cardioneuroablation for treatment of atrioventricular block: to cure the patient or the electrocardiogram?	38
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	38
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database	37
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	37
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	37
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation	36
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	36
Does the rhythm have an additional effect - left atrial strain measurement in heart failure patients with HFrEF and in patients with atrial fibrillation and preserved ejection fraction	36
Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis	36
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	36
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	36
Ultra-high density mapping and ablation of localized microreentrant tachycardias: insight from the CHARISMA registry	36
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	36
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	36
Simplification of resetting response in slow/fast atrioventricular nodal reentrant tachycardia: the 3 catheters approach	36
Imaging-derived tissue visualization guides catheter ablation of premature ventricular contractions	35
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	35
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	35
The novel POLARx ablation system improves cryothermal single-shot guided pulmonary vein isolation: impact of individual pulmonary vein anatomy	34
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators	33
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with non-ischemic dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden card	33
Utilising the pericardial CO2 insufflation technique to facilitate endo-epicardial AF ablation, achieving linear radiofrequency lesion sets, for persistent atrial fibrillation	33
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	33
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	32
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	32
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	32
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry	31
Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events	31
Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway	31
Novel four-exon deletion in ryanodine receptor gene (RYR2) associated with mixed electric and structural cardiac phenotype	31
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	31
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	31
Manual compression versus modified figure-of-8 stitch after left atrial ablations: a comparative randomized trial	31
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	31
Impact of sodium-glucose co-transporter inhibitors on cardiac autonomic function and mortality: no time to die	31
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network	30
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	30
Permanent epicardial pacing : a first line strategy in children	30
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of ‘ground truth’	30
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the nat	29
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall	29
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	29
Underlying reasons for sex difference in survival following out-of-hospital cardiac arrest: a mediation analysis	29
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?	29
Carbon footprint of atrial fibrillation catheter ablation	29
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	29
Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	29
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy	28
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), an	28
Atrial fibrillation and heart failure temporality: does it matter?	28
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	28
Corrigendum to: Infanticide vs. inherited cardiac arrhythmias	28
Comparison of quality-of-life following cryoballoon versus radiofrequency catheter ablation of symptomatic atrial fibrillation - a subanalysis of the FREEZE cohort study	28
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review	28
Prevalence and characteristics of arrhythmias during the pregnancy	28
Transvenous lead extraction: Experience of the Tandem approach	28
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients	28
Predicting dementia in patients with atrial fibrillation using machine learning of a large multimodal registry	27
Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study	27
Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation	27
In memoriam: Stuart J. Connolly, MD, 9 April 1949–2 June 2024	27
Determinants of mortality after stereotactic radio-ablation for ventricular tachycardia. Results from the international MUSIC consortium	27
Left-bundle branch block, an alert for cardiac resynchronization therapy	27
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?	27
Zero- and minimal fluoroscopic approaches during ablation of supraventricular tachycardias: A systematic review and meta-analysis	27
Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz	27
Long-term outcome after catheter ablation for fascicular ventricular tachycardia in a single high-volume center in Germany	27
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation	27
Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis	26
Biatrial ablation versus left atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease undergoing valve surgery: a systematic review and meta-analysis	26
Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation	26
Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection	25
Evidence for a shift from right ventricular to left ventricular outflow tract origin of idiopathic premature ventricular contractions with advancing age	25
Pulmonary vein isolation with additional substrate ablation for atrial fibrillation results in an increased risk for the development of atypical atrial flutter	25
Volume-weighted unipolar voltage identifies diffuse fibrosis in patients with non-ischemic cardiomyopathy	25
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation	25
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation	25
Non-standard approach for device selection. Left bundle branch optimized ICD for patients with heart failure and LBBB	25
Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation	24
Electrophysiologic effects of left bundle branch area pacing: comparing left ventricular septal pacing and left bundle branch pacing	24

Very-early detection of atrial fibrillation in patients after ablation evaluated by a home-based wearable ECG-patch	24
Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source	24
Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation	24
Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator	24
Zero fluro compared to fluoroscopy guided radiofrequency ablation of typical atrial flutter	24
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarisation analysed from 5-minute resting electrocardiogram in coronary artery disease	24
The impact of atrial fibrillation and atrial tachycardias on the hemodynamic status of patients with pulmonary hypertension	24
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis	24
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project	24
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation	24
An automatic single beat algorithm to discriminate farfield from nearfield bipolar voltage electrograms from the pulmonary veins	24
Non-invasive identification of deceleration zones in the atria using imageless ECGI: correlation with contact-mapping	24
What determines who gets cardiac resynchronization therapy in europe?	24
Renal denervation for the management of refractory ventricular arrhythmias	23
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome	23
Shift work and incident atrial fibrillation in younger and older individuals	23
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study	23
Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease	23
Weight-loss management after catheter ablation of atrial fibrillation	23
Optimal timing of of cardiac implantable electronic device reoperation	23
Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?	23
Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy	23
Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm	23
First-line Marshall plan approach in persistent atrial fibrillation: a prospective single-center cohort study	23
Genotype-phenotype correlation in hypertrophic cardiomyopathy: moving towards precision medicine?	23
Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation	23
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family	23
Identifying (electrophysiological) predictors of atrial fibrillation recurrences after catheter ablation: first results from the ISOLATION registry	22
Impact of contact force on local impedance measurements in different atrial locations	22
A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis	22
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis	22
Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility, and diagnostic value in complex ablation procedures	22
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates	22
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions	22
In silico biatrial fibrosis ablation improves atrial fibrillation outcome	22
Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker	22
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden	22
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type	22
Apical versus septal pacing - can we chose the localization of ventricular lead in order to prevent upgrade to cardiac resynchronization therapy?	22
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study	22
Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study	22
Additional coils mitigate elevated defibrillation threshold in right-sided implantable cardioverter defibrillator generator placement: a simulation study	22
Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016–2019 national readmission database	22
Selective sparing of Purkinje fibres with pulsed-field myocardial ablation	21
Non-invasive delineation of ventricular tachycardia substrates for cardiac stereotactic body radiotherapy: utility of in-silico pace-mapping	21
Single-center outcome after ablation of atrial fibrillation using very high-power short duration pulmonary vein isolation	21
Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy	21
First clinical experience with cardiac magnetic resonance guided typical atrial flutter ablation with the integration of active catheter tracking and electro-anatomical mapping	21
Ventricular septal defect characteristics influence presence and properties of septal anatomical isthmuses in patients with repaired tetralogy of Fallot	21
Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study	21
Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing	21
Recurrent variant of unknown significance in KCNH2 classified through functional characterisation	21
Genetic testing in children with Brugada syndrome: results from a large prospective registry	21
Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project	21
The effect of thresholding techniques on 3D quantitative scar metrics in patients with implantable cardioverter defibrillator	20
P-wave duration and atrial fibrillation recurrence after catheter ablation, a systematic review and meta-analysis	20
Epicardial mapping as first intention approach for structural ventricular tachycardia ablation	20
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification	20
Pinpointing atrial fibrillation drivers by informed sequential endocardial mapping in the presence and absence of fibrosis: an in-silico study	20
Fluoroless cavotricuspid isthmus radiofrequency ablation of typical atrial flutter achieves success with zero radiation and shorter procedural duration	20
AV block occurrence in normal AV conduction CRT fusion pacing: single center experience	20
Validation of a machine learning algorithm to identify pulmonary vein isolation during ablation procedures for the treatment of atrial fibrillation: results of the PVISION study	20
Relationship between electrical activity and left atrial volume during atrial fibrillation	20
High comorbidity burden is not associated with increased risk of periprocedural pericardial effusionduring left atrial ablation procedures: data from a large tertiary-care ablation center	20
Novelty about pocket histology at cardiac implantable electronic device reopening procedures	19
Vascular complications of pulsed-field ablation of atrial fibrillation using a streamlined procedural workflow - when less is not more	19
Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience	19
Risk factors of mortality after secondary procedures during the world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT)	19
Endocardial pacing results in better electrical resynchronization and hemodynamic improvement than epicardial pacing in CRT	19
Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic	19
A novel score to predict left atrial appendage thrombus and sludge in patients with persistent atrial fibrillation on chronic anticoagulants	19
Myeloperoxidase as prognostic factor for atrial fibrillation development in patients with ST-segment elevation myocardial infarction	19
Left bundle branch pacing with normal paced QRS axis produce more physiological left ventricular lateral wall depolarization than its pacing resulting in heart axis deviation	19
Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?	19
Procedural safety, short and long-term follow up after pacemaker implantation in nonagenarians	19
Re-recognized the maintenance mechanism of persistent atrial fibrillation via electrogram analysis in termination regions	19
Deep septal pacing for pacemaker-induced cardiomyopathy	18
Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome	18
A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study)	18
Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality	18
Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation	18
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement	18
Septal venous channel perforation during left bundle branch area pacing: a prospective study	18
Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure	18
Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk	18
Differential effect of high-frequency electroporation on myocardium vs. non-myocardial tissues	18
Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: single-centre retrospective study with consistent provocation protocol	18
Software-based analysis of T-wave morphology: identifying the electrocardiogram signature of high-risk long QT syndrome	18
Leap or lag: left atrial appendage closure and guidelines	18
360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation	18
Wearable Smartwatches for Atrial Fibrillation Detection and Burden Estimation After Ablation: Comparison With Continuous Monitoring	18
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study	18
Use of three-dimensional electroanatomic mapping for epicardial access: needle tracking, electrographic characteristics, and clinical application	18
Assessing V6 RWPT and V6-V1 interpeak time as conduction system capture criteria in non-basal LBBAP lead positions	17
Detailed analysis of PAC characteristics in ambulatory ECG data can improve atrial fibrillation risk prediction	17